Making Sense of a Rare Robinson-Patman Act Plaintiffs’ Verdict

By , and on June 12, 2024

On May 20, 2024, US District Court Judge Michael W. Fitzgerald rejected a popular over-the-counter eyedrop seller’s bid for a new trial and granted a pricing injunction impacting two large wholesale membership clubs following one of very few Robinson-Patman Act (RPA) plaintiff-side jury verdicts in recent years.

The case, L.A. International Corporation v. Prestige Brands Holdings, Inc., centered around popular eye drops called Clear Eyes® (Clear Eyes) sold by Medtech Products Inc. (Medtech) to wholesalers. The plaintiffs – a group of regional wholesalers (Plaintiffs) who purchased Clear Eyes for resale to retailers – sued Medtech and its parent company, Prestige Consumer Healthcare Inc. (together, Medtech or Defendants), in the US District Court for the Central District of California in August 2018.

Read more here.

Ryan Tisch
Ryan Tisch provides strategic antitrust counsel for boards of directors, chief executive officers and key business stakeholders as they maneuver government regulations around the world. He is known for securing approvals for significant mergers facing review in multiple jurisdictions, including some of the largest mergers in the communications, manufacturing, technology, and food and beverage industries. As the digital economy exposes traditional businesses to new competition, clients also turn to Ryan to advise on their evolving business platforms and go-to-market strategies. Read Ryan Tisch's full bio. 

Alex Grayson
Alex Grayson focuses his practice on antitrust and competition matters and employment litigation. Read Alex Grayson's full bio. 

Glenna Siegel
Glenna Siegel focuses her practice on antitrust and competition legal matters including litigation, government investigations, merger clearance and regulatory compliance. Read Glenna Siegel's full bio.





Ranked In Chambers USA 2022
US Leading Firm 2022